Bone SarcomaCancerBones and joints
What this study is
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
What's being tested
- Non-Interventional Study
Intervention · OTHER
Non-interventional study
Study details
- Official title
- Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography
- Sponsor
- Mayo Clinic
- Conditions
- Bone Sarcoma · Soft Tissue Sarcoma
- Enrolling
- 75 people
- Starts
- 2024-03-14
- Est. completion
- 2027-03-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection
You can't join if
- Chronic kidney disease
- Anaphylaxis to dyes
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic in Rochester
Rochester, Minnesota, United States
- Clinical Trials Referral Office · Contact855-776-0015mayocliniccancerstudies@mayo.edu
- Laura Dohrmann · Contact507-266-5886Beinborn.Laura@mayo.edu
- Matthew T. Houdek, M.D. · Principal investigator
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 23-003589
Principal investigator
Matthew T. Houdek, M.D.
Mayo Clinic in Rochester
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.